Market Capitalization (Millions $) |
2 |
Shares
Outstanding (Millions) |
1 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-6 |
Cash Flow (TTM) (Millions $) |
-5 |
Capital Exp. (TTM) (Millions $) |
0 |
Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in Charlottesville, Virginia. The company focuses on the development of precision medicines for the treatment of alcohol use disorder (AUD) and other addictive disorders. Adial Pharmaceuticals' lead product is AD04, a therapeutic compound designed to reduce the desire to consume alcohol. The company aims to address the significant unmet need for effective pharmacotherapies for AUD, which currently lacks adequate treatment options. Adial Pharmaceuticals is committed to improving the lives of individuals suffering from alcohol addiction through innovative research and development efforts.
Company Address: 1180 Seminole Trail Charlottesville 22901 VA
Company Phone Number: 422-9800 Stock Exchange / Ticker: NASDAQ ADIL
ADIL is expected to report next financial results on March 29, 2024. |
|
|